Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Lindhoff-Last

Showing results (51-60 of 56) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 56 results.
Hamostaseologie|November 2, 2012
[Risk of bleeding and haemorrhagic complication with rivaroxaban--periprocedural management of haemostasis]J Koscielny, J Beyer-Westendorf, C von Heymann, et al.
Thrombosis Research|March 1, 1994
Regression of deep vein thrombosis by i.v.-administration of a low molecular weight heparin--results of a pilot studyC M Kirchmaier, E Lindhoff-Last, D Rübesam, et al.
Journal of Thrombosis and Haemostasis : JTH|February 5, 2010
Heparin-induced non-necrotizing skin lesions: rarely associated with heparin-induced thrombocytopeniaM Schindewolf, H Kroll, H Ackermann, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|April 24, 2018
Low incidence of heparin-induced skin lesions in orthopedic surgery patients with low-molecular-weight heparinsM Schindewolf, M Paulik, H Kroll, et al.
European Journal of Internal Medicine|March 19, 2026
It's time to improve antithrombotic therapy! A global perspective for antithrombotic stewardshipW Ageno, L Bertoletti, E Lindhoff-Last, et al.
Hamostaseologie|November 2, 2012
[Dabigatran therapy--perioperative management and interpretation of coagulation tests]M Spannagl, R Bauersachs, E S Debus, et al.
Pageof 6

Showing results (51-60 of 56) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 56 results.
Hamostaseologie|November 2, 2012
[Risk of bleeding and haemorrhagic complication with rivaroxaban--periprocedural management of haemostasis]J Koscielny, J Beyer-Westendorf, C von Heymann, et al.
Thrombosis Research|March 1, 1994
Regression of deep vein thrombosis by i.v.-administration of a low molecular weight heparin--results of a pilot studyC M Kirchmaier, E Lindhoff-Last, D Rübesam, et al.
Journal of Thrombosis and Haemostasis : JTH|February 5, 2010
Heparin-induced non-necrotizing skin lesions: rarely associated with heparin-induced thrombocytopeniaM Schindewolf, H Kroll, H Ackermann, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|April 24, 2018
Low incidence of heparin-induced skin lesions in orthopedic surgery patients with low-molecular-weight heparinsM Schindewolf, M Paulik, H Kroll, et al.
European Journal of Internal Medicine|March 19, 2026
It's time to improve antithrombotic therapy! A global perspective for antithrombotic stewardshipW Ageno, L Bertoletti, E Lindhoff-Last, et al.
Hamostaseologie|November 2, 2012
[Dabigatran therapy--perioperative management and interpretation of coagulation tests]M Spannagl, R Bauersachs, E S Debus, et al.
Pageof 6